ALS
Sensorion
Stock
Stock
ISIN: FR0012596468
Ticker: ALSEN
FR0012596468
ALSEN
Price
Price
Frequently asked questions
What is Sensorion's market capitalization?
The market capitalization of Sensorion is $206.83M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Sensorion?
Sensorion's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.109. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sensorion's stock?
Currently, 5 analysts cover Sensorion's stock, with a consensus target price of $1.999. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for Sensorion?
Sensorion's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$23.77M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Sensorion?
Sensorion has a free cash flow of -$24.43M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of Sensorion's stock?
The 5-year beta for Sensorion is 1.44. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does Sensorion have, and what sector and industry does it belong to?
Sensorion employs approximately 61 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.
What is the free float of Sensorion's shares?
The free float of Sensorion is 211.83M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$206.83M5Y beta
1.44EPS (TTM)
-$0.109Free Float
211.83MEBITDA (TTM)
-$23.77MFree Cashflow (TTM)
-$24.43MPricing
1D span
$0.641$0.698
52W span
$0.444$1.126
Analyst Ratings
The price target is $1.999 and the stock is covered by 5 analysts.
Buy
5
Hold
0
Sell
0
Information
Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.
61
Biotechnology & Drugs
Health Care
Identifier
ISIN
FR0012596468
Primary Ticker
ALSEN